Lymphoma Newsletter

Sep 11, 2018-edited

Stay Current With Lymphoma Treatment Advances & Connect with Others

CancerConnect publishes daily cancer news, original articles and "tips" on the management of lymphoma. These are available in our monthly lymphoma newsletter.

Stay Current - Connect With Other Lymphoma Patients

Join The CancerConnect Community: Connect with others and receive regular updates

Sign up for the Lymphoma Newsletter Here

Comments

Overview of Non Hodgkins Lymphoma

Understanding Lymphomas: Risks, Causes, Evaluation, Staging and Treatment Planning.

Cancer Connect

Mar 4

The Non Hodgkins Lymphoma Community - Connect With Other NHL Patients

Connect with Others at Top Cancer Centers - Second Opinion Options...

TraceyS

May 6

Lymphoma Classifications

Classification of Non-Hodgkin Lymphomas is necessary to determine treatment.

Cancer Connect

Sep 21, 2018

R-CHOP Treatment for Non-Hodgkin Lymphoma

Research demonstrates that some patients with NHL can be treated with 4 instead of 6 cycles of R-CHOP.

MedMaven

Oct 2

High Dose Chemotherapy and Stem Cell Transplant for Highly Aggressive NHL

Overview of Autologous Stem Cell Transplant for treatment of Burkitts, small cleaved and highly aggressive NHL

Cancer Connect

Mar 6

Diagnosed with Lymphoma: 10 Tips on How to Get The Most From Your Doctor

Ten things every patient with lymphoma should consider in order to get the best possible treatment

MedMaven

May 31

A New Drug, Pentostatin, is Promising for Treatment of T-Cell Lymphomas

T-cell lymphomas frequently involve the skin and have a variable, but in general, poor outcome with current treatment.

Cancer Connect

Mar 8, 2009

Treanda-Rituxan-Polivy Represents new Treatment Option for Recurrent DLBCL

FDA Approves Chemoimmunotherapy Regimen for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma

MedMaven

Jun 10

Jury Determines That Monsanto’s Roundup Responsible for Lymphoma - EPA Disagrees

Superior court jury decides NHL was at least partly caused by glyphosate, an ingredient in RoundUp. US EPA Disagrees

MedMaven

May 6

Umbralisib A Potential New Treatment for Marginal Zone Lymphoma

PI3K inhibitors are a promising new therapy for the management of b cell lymphomas and are being evaluated in MZL.

MedMaven

Jun 11

Cancer Connect

The Spine Community

theRAconnection

Osteoporosis

Women's Health

Lymphoma Newsletter

Stay Current - Connect With Other Lymphoma Patients

Cancer Connect

The Spine Community

theRAconnection

Osteoporosis

Women's Health

CancerConnect Lymphoma Newsletter

Stay Current - Connect With Other Lymphoma Patients